Electrophysiology, Pharmacology and Sudden Cardiac Death

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Electrophysiology

Pharmacology

Sudden Cardiac Death

PO-05-201 PHARMACOLOGICAL MODULATION OF THE ARRHYTHMIC SUBSTRATE IN TIMOTHY SYNDROME: A PORCINE MODEL STUDY

HeartRhythm

APRIL 30, 2024

Contemporary antiarrhythmic treatment of Timothy syndrome 1 (TS1) is inadequate to prevent sudden cardiac death. Using electroanatomic mapping (EAM) we discovered cardiac activation delay, which creates the milieu for functional reentrant ventricular arrhythmias.

Sudden Cardiac Death

Sudden Cardiac Death Pharmacology Electrophysiology Arrhythmia

American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines

DAIC

MAY 9, 2024

New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.

Cardiomyopathy

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death

Cardiovascular Update

PO-05-201 PHARMACOLOGICAL MODULATION OF THE ARRHYTHMIC SUBSTRATE IN TIMOTHY SYNDROME: A PORCINE MODEL STUDY

American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines

Stay Connected